STOCK TITAN

[D] Flora Growth Corp. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
D

Flora Growth Corp. filed a Form D notifying the SEC of a Regulation D exempt private offering of equity and associated warrants. The offering size is $4,233,401 with $3,554,950 already sold and $678,451 remaining, which the filer says reflects the maximum potential exercise price of outstanding warrants. The securities include equity, cash warrants exercisable at $25.19 until September 25, 2030, and prefunded warrants that expire upon full exercise. The sale began with a first sale on 2025-09-26, the offering is intended to last more than one year, and Flora Growth reports 11 investors to date. No sales commissions or finders' fees are reported and no proceeds were allocated to named officers, directors or promoters.

Flora Growth Corp. ha presentato una Form D comunicando alla SEC un'offerta privata esente Regolamento D di capitale proprio e warrant associati. Le dimensioni dell'offerta sono $4,233,401 con $3,554,950 già venduti e $678,451 rimasti, che l'inseritore afferma riflettere il prezzo massimo potenziale di esercizio dei warrant in circolazione. I titoli includono capitale proprio, warrant in contanti esercitabili a $25.19 fino al 25 settembre 2030, e warrant anticipati che scadono al completo esercizio. La vendita è iniziata con una prima vendita il 26 settembre 2025, l'offerta dovrebbe durare più di un anno, e Flora Growth riporta 11 investitori ad oggi. Nessuna commissione di vendita o onorario di intermediazione è riportata e nessun provento è stato assegnato a funzionari, direttori o promotori nominati.

Flora Growth Corp. presentó un Form D notificando a la SEC una oferta privada exenta bajo la Regla D de capital privado y warrants asociados. El tamaño de la oferta es $4,233,401 con $3,554,950 ya vendido y $678,451 pendiente, que el solicitante dice que refleja el precio máximo potencial de ejercicio de los warrants en circulación. Los valores incluyen capital, warrants en efectivo exercitables a $25.19 hasta el 25 de septiembre de 2030, y warrants prefinanciados que expiran al completarse el ejercicio. La venta comenzó con la primera venta el 26 de septiembre de 2025, la oferta se pretende mantener por más de un año, y Flora Growth reporta 11 inversionistas hasta la fecha. No se reportan comisiones de venta ni honorarios de intermediarios y no se asignaron ingresos a directivos, directores o promotores nombrados.

Flora Growth Corp.는 SEC에 Regulation D 면제 비상장 주식 공모 및 관련 워런트를 알리는 Form D를 제출했습니다. 공모 규모는 $4,233,401이고 $3,554,950가 이미 매각되었으며 $678,451가 남아 있는데, 이는 미결 워런트의 행사 가격의 최대 잠재치를 반영한다고 제출자는 말합니다. 증권은 자본금, $25.19의 현금 워런트가 2030년 9월 25일까지 행사 가능하며, 전면 행사 시 만료되는 선발매 워런트도 포함합니다. 매각은 2025-09-26에 처음 매매로 시작되었고, 공모는 1년 이상 지속될 예정이며 Flora Growth는 현재 11명의 투자자를 보고합니다. 판매 수수료나 중개 수수료는 보고되지 않았고, 이름이 기재된 임원, 이사 또는 홍보인에게 발생한 수익도 배분되지 않았습니다.

Flora Growth Corp. a déposé un formulaire D informant la SEC d'une offre privée exonérée par le Règlement D d'actions et de warrants associés. La taille de l'offre est $4,233,401 avec $3,554,950 déjà vendus et $678,451 restants, ce que le déclarant affirme refléter le prix d'exercice maximal potentiel des warrants en circulation. Les titres comprennent des actions, des warrants en espèces exerçables à $25.19 jusqu’au 25 septembre 2030, et des warrants préfinancés qui expirent à l’exercice complet. La vente a commencé par une première vente le 26 septembre 2025, l’offre est destinée à durer plus d’un an, et Flora Growth déclare à ce jour 11 investisseurs. Aucune commission de vente ni frais de courtage n’est rapporté et aucun produit n’a été attribué à des dirigeants nommés, administrateurs ou promoteurs.

Flora Growth Corp. hat ein Form D eingereicht, um der SEC eine private Angebotserlaubnis nach Regulation D von Eigenkapital und zugehörigen Warrants mitzuteilen. Die Größe des Angebots beträgt $4,233,401, von dem $3,554,950 bereits verkauft wurden und $678,451 verbleiben, was der Einreicher als maximale potenzielle Ausübungskosten der ausstehenden Warrants angibt. Die Wertpapiere umfassen Eigenkapital, Bar-Warrants, die bis $25.19 exercisierbar sind bis zum 25. September 2030, und vorfinanzierte Warrants, die bei vollständiger Ausübung verfallen. Der Verkauf begann mit einem Erstverkauf am 26. September 2025, die Offer soll länger als ein Jahr dauern, und Flora Growth meldet bislang 11 Investoren. Es werden keine Verkaufsprovisionen oder Vermittlergebühren gemeldet und keine Erlöse wurden an benannte/bezeichnete Offiziere, Direktoren oder Promotoren zugewiesen.

Flora Growth Corp. قد قدمت نموذج D لإبلاغ هيئة الأوراق المالية SEC بعرض خاص معفي من Regulation D لحقوق الملكية والـ warrants المرتبطة. حجم العرض هو $4,233,401 مع $3,554,950 بيع بالفعل و$678,451 متبقياً، وهو ما يقول المُقدم إنه يعكس الحد الأقصى لسعر تمكين الاستغلال للوارد التي في التداول. الأوراق المالية تشمل حقوق الملكية، وWarrants نقدية قابلة للتدريب عند $25.19 حتى 25 سبتمبر 2030، وWarrants مُمَهَّأة تنتهي عند الممارسة الكاملة. بدأ البيع ببيع أول في 26 سبتمبر 2025، ومن المفترض أن يستمر العرض لأكثر من عام، وتذكر Flora Growth حتى الآن 11 مستثمر. لا تقارير عن عمولات بيع أو كُلف الوسطاء ولم يتم تخصيص أي عائدات إلى موظفين مقيمين، مدراء أو مروِّجين معينين.

Flora Growth Corp. 提交了 Form D,通知美国证券交易委员会有关 Regulation D 免税私募发行股票及相关认股权证。发行规模为 $4,233,401,已售出 $3,554,950,尚余 $678,451,发行人表示这反映了未到期认股权证的最大潜在执行价格。证券包括股权、可执行至 $25.19 的现金认股权证,至 2030-09-25 到期,以及在完全行使时失效的预先资助的认股权证。销售于 2025-09-26 开始首次销售,公开募集预计持续超过一年,Flora Growth 目前报告 11 名投资者。未报告任何销售佣金或中介费,且未将任何收益分配给任命的高管、董事或推介人。

Positive
  • $3,554,950 already raised toward a $4.23M offering, showing early investor support
  • No reported sales commissions or finders' fees, preserving proceeds for corporate use
  • 11 investors indicate some market demand without broad retail distribution
Negative
  • Remaining $678,451 tied to potential warrant exercises that could dilute existing shareholders
  • Warrants exercisable at $25.19 through September 25, 2030 create long‑dated dilution uncertainty
  • Offering intended to last more than one year, delaying full capital clarity and timing of cash inflows

Insights

Equity raise with warrants extends capitalization and potential dilution.

Flora Growth accessed exempt private capital totaling $3.55M sold, leaving $678K in potential warrant exercise proceeds. The mix of equity and long‑dated cash warrants at $25.19 introduces a multi‑year dilution vector if exercised through 2030.

The offering's longevity (> one year) and 11 current investors means capital availability is staged; monitor actual warrant exercises and any price movement toward the $25.19 strike within the next 1–5 years for dilution and cash inflow impact.

Regulation D Rule 506(b) filing; standard disclosures and investor limits.

The issuer claims an exemption under Rule 506(b), filed a New Notice with a first sale date of 2025-09-26, and certifies no commissions or payments to related persons. The Form D lists 11 investors and confirms the offering may continue beyond one year, which is permissible under the exemption.

Key items to watch are whether the issuer maintains eligibility for Rule 506(b) and any state notice filings; if additional non‑accredited investors participate or sales practices change, further disclosure or different exemptions could be required within 12 months.

Flora Growth Corp. ha presentato una Form D comunicando alla SEC un'offerta privata esente Regolamento D di capitale proprio e warrant associati. Le dimensioni dell'offerta sono $4,233,401 con $3,554,950 già venduti e $678,451 rimasti, che l'inseritore afferma riflettere il prezzo massimo potenziale di esercizio dei warrant in circolazione. I titoli includono capitale proprio, warrant in contanti esercitabili a $25.19 fino al 25 settembre 2030, e warrant anticipati che scadono al completo esercizio. La vendita è iniziata con una prima vendita il 26 settembre 2025, l'offerta dovrebbe durare più di un anno, e Flora Growth riporta 11 investitori ad oggi. Nessuna commissione di vendita o onorario di intermediazione è riportata e nessun provento è stato assegnato a funzionari, direttori o promotori nominati.

Flora Growth Corp. presentó un Form D notificando a la SEC una oferta privada exenta bajo la Regla D de capital privado y warrants asociados. El tamaño de la oferta es $4,233,401 con $3,554,950 ya vendido y $678,451 pendiente, que el solicitante dice que refleja el precio máximo potencial de ejercicio de los warrants en circulación. Los valores incluyen capital, warrants en efectivo exercitables a $25.19 hasta el 25 de septiembre de 2030, y warrants prefinanciados que expiran al completarse el ejercicio. La venta comenzó con la primera venta el 26 de septiembre de 2025, la oferta se pretende mantener por más de un año, y Flora Growth reporta 11 inversionistas hasta la fecha. No se reportan comisiones de venta ni honorarios de intermediarios y no se asignaron ingresos a directivos, directores o promotores nombrados.

Flora Growth Corp.는 SEC에 Regulation D 면제 비상장 주식 공모 및 관련 워런트를 알리는 Form D를 제출했습니다. 공모 규모는 $4,233,401이고 $3,554,950가 이미 매각되었으며 $678,451가 남아 있는데, 이는 미결 워런트의 행사 가격의 최대 잠재치를 반영한다고 제출자는 말합니다. 증권은 자본금, $25.19의 현금 워런트가 2030년 9월 25일까지 행사 가능하며, 전면 행사 시 만료되는 선발매 워런트도 포함합니다. 매각은 2025-09-26에 처음 매매로 시작되었고, 공모는 1년 이상 지속될 예정이며 Flora Growth는 현재 11명의 투자자를 보고합니다. 판매 수수료나 중개 수수료는 보고되지 않았고, 이름이 기재된 임원, 이사 또는 홍보인에게 발생한 수익도 배분되지 않았습니다.

Flora Growth Corp. a déposé un formulaire D informant la SEC d'une offre privée exonérée par le Règlement D d'actions et de warrants associés. La taille de l'offre est $4,233,401 avec $3,554,950 déjà vendus et $678,451 restants, ce que le déclarant affirme refléter le prix d'exercice maximal potentiel des warrants en circulation. Les titres comprennent des actions, des warrants en espèces exerçables à $25.19 jusqu’au 25 septembre 2030, et des warrants préfinancés qui expirent à l’exercice complet. La vente a commencé par une première vente le 26 septembre 2025, l’offre est destinée à durer plus d’un an, et Flora Growth déclare à ce jour 11 investisseurs. Aucune commission de vente ni frais de courtage n’est rapporté et aucun produit n’a été attribué à des dirigeants nommés, administrateurs ou promoteurs.

Flora Growth Corp. hat ein Form D eingereicht, um der SEC eine private Angebotserlaubnis nach Regulation D von Eigenkapital und zugehörigen Warrants mitzuteilen. Die Größe des Angebots beträgt $4,233,401, von dem $3,554,950 bereits verkauft wurden und $678,451 verbleiben, was der Einreicher als maximale potenzielle Ausübungskosten der ausstehenden Warrants angibt. Die Wertpapiere umfassen Eigenkapital, Bar-Warrants, die bis $25.19 exercisierbar sind bis zum 25. September 2030, und vorfinanzierte Warrants, die bei vollständiger Ausübung verfallen. Der Verkauf begann mit einem Erstverkauf am 26. September 2025, die Offer soll länger als ein Jahr dauern, und Flora Growth meldet bislang 11 Investoren. Es werden keine Verkaufsprovisionen oder Vermittlergebühren gemeldet und keine Erlöse wurden an benannte/bezeichnete Offiziere, Direktoren oder Promotoren zugewiesen.

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM D

Notice of Exempt Offering of Securities

OMB APPROVAL
OMB Number: 3235-0076
Estimated average burden
hours per response: 4.00

1. Issuer's Identity

CIK (Filer ID Number) Previous Names
X None
Entity Type
0001790169
X Corporation
Limited Partnership
Limited Liability Company
General Partnership
Business Trust
Other (Specify)

Name of Issuer
Flora Growth Corp.
Jurisdiction of Incorporation/Organization
ONTARIO, CANADA
Year of Incorporation/Organization
X Over Five Years Ago
Within Last Five Years (Specify Year)
Yet to Be Formed

2. Principal Place of Business and Contact Information

Name of Issuer
Flora Growth Corp.
Street Address 1 Street Address 2
3230 W. COMMERCIAL BOULEVARD SUITE 180
City State/Province/Country ZIP/PostalCode Phone Number of Issuer
FORT LAUDERDALE FLORIDA 33309 604-609-0244

3. Related Persons

Last Name First Name Middle Name
Reis-Faria Daniel
Street Address 1 Street Address 2
3230 W. COMMERCIAL BOULEVARD SUITE 180
City State/Province/Country ZIP/PostalCode
FORT LAUDERDALE FLORIDA 33309
Relationship: X Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Heinrich Michael
Street Address 1 Street Address 2
3230 W. COMMERCIAL BOULEVARD SUITE 180
City State/Province/Country ZIP/PostalCode
FORT LAUDERDALE FLORIDA 33309
Relationship: X Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Vaiman Dany
Street Address 1 Street Address 2
3230 W. COMMERCIAL BOULEVARD SUITE 180
City State/Province/Country ZIP/PostalCode
FORT LAUDERDALE FLORIDA 33309
Relationship: X Executive Officer Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Woo Edward
Street Address 1 Street Address 2
3230 W. COMMERCIAL BOULEVARD SUITE 180
City State/Province/Country ZIP/PostalCode
FORT LAUDERDALE FLORIDA 33309
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Leventhal Manfred
Street Address 1 Street Address 2
3230 W. COMMERCIAL BOULEVARD SUITE 180
City State/Province/Country ZIP/PostalCode
FORT LAUDERDALE FLORIDA 33309
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


4. Industry Group

Agriculture
Banking & Financial Services
Commercial Banking
Insurance
Investing
Investment Banking
Pooled Investment Fund
Is the issuer registered as
an investment company under
the Investment Company
Act of 1940?
Yes No
Other Banking & Financial Services
Business Services
Energy
Coal Mining
Electric Utilities
Energy Conservation
Environmental Services
Oil & Gas
Other Energy
Health Care
Biotechnology
Health Insurance
Hospitals & Physicians
Pharmaceuticals
Other Health Care
Manufacturing
Real Estate
Commercial
Construction
REITS & Finance
Residential
Other Real Estate
Retailing
Restaurants
Technology
Computers
Telecommunications
Other Technology
Travel
Airlines & Airports
Lodging & Conventions
Tourism & Travel Services
Other Travel
X
Other

5. Issuer Size

Revenue Range OR Aggregate Net Asset Value Range
No Revenues No Aggregate Net Asset Value
$1 - $1,000,000 $1 - $5,000,000
$1,000,001 - $5,000,000 $5,000,001 - $25,000,000
$5,000,001 - $25,000,000 $25,000,001 - $50,000,000
$25,000,001 - $100,000,000 $50,000,001 - $100,000,000
Over $100,000,000 Over $100,000,000
X Decline to Disclose Decline to Disclose
Not Applicable Not Applicable

6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)

Rule 504(b)(1) (not (i), (ii) or (iii))
Rule 504 (b)(1)(i)
Rule 504 (b)(1)(ii)
Rule 504 (b)(1)(iii)
X Rule 506(b)
Rule 506(c)
Securities Act Section 4(a)(5)
Investment Company Act Section 3(c)
Section 3(c)(1) Section 3(c)(9)
Section 3(c)(2) Section 3(c)(10)
Section 3(c)(3) Section 3(c)(11)
Section 3(c)(4) Section 3(c)(12)
Section 3(c)(5) Section 3(c)(13)
Section 3(c)(6) Section 3(c)(14)
Section 3(c)(7)

7. Type of Filing

X New Notice Date of First Sale 2025-09-26 First Sale Yet to Occur
Amendment

8. Duration of Offering

Does the Issuer intend this offering to last more than one year?
X Yes No

9. Type(s) of Securities Offered (select all that apply)

X Equity Pooled Investment Fund Interests
Debt Tenant-in-Common Securities
X Option, Warrant or Other Right to Acquire Another Security Mineral Property Securities
X Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security X Other (describe)
Cash warrants exerciseable at $25.19 until September 25, 2030. Prefunded warrants expire when exercised in full.

10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
Yes X No

Clarification of Response (if Necessary):

11. Minimum Investment

Minimum investment accepted from any outside investor $0 USD

12. Sales Compensation

Recipient
Recipient CRD Number X None
(Associated) Broker or Dealer X None
(Associated) Broker or Dealer CRD Number X None
Street Address 1 Street Address 2
City State/Province/Country ZIP/Postal Code
State(s) of Solicitation (select all that apply)
Check "All States" or check individual States
All States
Foreign/non-US

13. Offering and Sales Amounts

Total Offering Amount $4,233,401 USD
or Indefinite
Total Amount Sold $3,554,950 USD
Total Remaining to be Sold $678,451 USD
or Indefinite

Clarification of Response (if Necessary):

Total amount remaining to be sold represents maximum potential exercise price of warrants.

14. Investors

Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, and enter the number of such non-accredited investors who already have invested in the offering.
Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering:
11

15. Sales Commissions & Finder's Fees Expenses

Provide separately the amounts of sales commissions and finders fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.

Sales Commissions $0 USD
Estimate
Finders' Fees $0 USD
Estimate

Clarification of Response (if Necessary):

16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.

$0 USD
Estimate

Clarification of Response (if Necessary):

Signature and Submission

Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.

Terms of Submission

In submitting this notice, each issuer named above is:
  • Notifying the SEC and/or each State in which this notice is filed of the offering of securities described and undertaking to furnish them, upon written request, in the accordance with applicable law, the information furnished to offerees.*
  • Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator or other legally designated officer of the State in which the issuer maintains its principal place of business and any State in which this notice is filed, as its agents for service of process, and agreeing that these persons may accept service on its behalf, of any notice, process or pleading, and further agreeing that such service may be made by registered or certified mail, in any Federal or state action, administrative proceeding, or arbitration brought against the issuer in any place subject to the jurisdiction of the United States, if the action, proceeding or arbitration (a) arises out of any activity in connection with the offering of securities that is the subject of this notice, and (b) is founded, directly or indirectly, upon the provisions of: (i) the Securities Act of 1933, the Securities Exchange Act of 1934, the Trust Indenture Act of 1939, the Investment Company Act of 1940, or the Investment Advisers Act of 1940, or any rule or regulation under any of these statutes, or (ii) the laws of the State in which the issuer maintains its principal place of business or any State in which this notice is filed.
  • Certifying that, if the issuer is claiming a Regulation D exemption for the offering, the issuer is not disqualified from relying on Rule 504 or Rule 506 for one of the reasons stated in Rule 504(b)(3) or Rule 506(d).

Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.

For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.

Issuer Signature Name of Signer Title Date
Flora Growth Corp. /s/ Dany Vaiman Dany Vaiman CFO 2025-10-09

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

* This undertaking does not affect any limits Section 102(a) of the National Securities Markets Improvement Act of 1996 ("NSMIA") [Pub. L. No. 104-290, 110 Stat. 3416 (Oct. 11, 1996)] imposes on the ability of States to require information. As a result, if the securities that are the subject of this Form D are "covered securities" for purposes of NSMIA, whether in all instances or due to the nature of the offering that is the subject of this Form D, States cannot routinely require offering materials under this undertaking or otherwise and can require offering materials only to the extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.


FAQ

What amount has Flora Growth (FLGC) raised in the Form D offering?

The filing reports $3,554,950 sold of a total $4,233,401 offering, leaving $678,451 remaining.

What types of securities are offered in the FLGC Form D?

The offering includes equity, cash warrants exercisable at $25.19 until September 25, 2030, and prefunded warrants that expire upon full exercise.

Under which exemption was Flora Growth (FLGC) offering its securities?

The issuer claimed an exemption under Rule 506(b) of Regulation D.

How many investors participated in the offering so far for FLGC?

The Form D lists a total of 11 investors to date.

Were any sales commissions or finders' fees paid in this FLGC offering?

No; the filing reports $0 in sales commissions and $0 in finders' fees.
Flora Growth Corp

NASDAQ:FLGC

FLGC Rankings

FLGC Latest News

FLGC Latest SEC Filings

FLGC Stock Data

13.55M
639.80k
12.54%
4.08%
1.14%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
FORT LAUDERDALE